Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Amended and Restated Certificate of Incorporation
- 3.2 Amended and Restated Bylaws
- 10.4 Joinder to the Estrella Series a Purchase Agreement by and Between Estrella Biopharma, Inc. and Lianhe World Limited
- 10.5 Joinder to the Estrella Series a Purchase Agreement by and Between Estrella Biopharma, Inc. and Cofame Investments, LLC
- 10.6 Joinder to the Estrella Series a Purchase Agreement by and Between Estrella Biopharma, Inc. and Us Tiger Securities, Inc
- 10.7 Joinder to the Estrella Series a Purchase Agreement by and Between Estrella Biopharma, Inc. and Smart Crest International Limited
- 10.8 Joinder to the Estrella Series a Purchase Agreement by and Between Estrella Biopharma, Inc. and Yangbing Xiao
- 10.9 Joinder to the Estrella Series a Purchase Agreement by and Between Estrella Biopharma, Inc. and Yuandong Wang
- 10.10 Stock Transfer Agreement by and Among Cheng Liu, Jiandong (Peter) Xu and Qian (Vicky) Yang, Yuandong Wang and Estrella Biopharma, Inc
- 10.11 Stock Transfer Agreement by and Among Cheng Liu, Jiandong (Peter) Xu and Qian (Vicky) Yang, Yangbing Xiao and Estrella Biopharma, Inc
- 10.12 Stock Transfer Agreement by and Among Cheng Liu, Jiandong (Peter) Xu and Qian (Vicky) Yang, Smart Crest International Limited and Estrella Biopharma, Inc
- 10.13 Form of Indemnification Agreement
- 10.14 Estrella Immunopharma, Inc. 2023 Omnibus Incentive Plan
- 10.15 Unsecured Promissory Note by and Between Hongbin Zhang and Estrella Biopharma Inc
- 10.16 Amendment to Offer Letter by and Between DR. Cheng Liu and Estrella Biopharma, Inc
- 10.17 Amendment to Employment Agreement by and Between Peter Xu and Estrella Biopharma, Inc
- 10.18 Amendment to Employment Agreement by and Between Vicky Yang and Estrella Biopharma, Inc
- 10.19 Employment Agreement by and Between DR. Cheng Liu and Estrella Immunopharma, Inc
- 10.20 Employment Agreement by and Between Peter Xu and Estrella Immunopharma, Inc
- 14.1 Code of Business Ethics and Conduct of Estrella Immunopharma, Inc
- 21.1 List of Subsidiaries
- 99.1 Unaudited Pro Forma Condensed Combined Financial Information of New Estrella As of and for the Six Months Ended June 30, 2023 and for the Year Ended December 31, 2022
- 99.2 Audited Financial Statements of Estrella As of June 30, 2023 and 2022, and for the Year Ended June 30, 2023, the Period from March 30, 2022 (Inception) Through June 30, 2022, and the Period from July 1, 2021 Through March 29, 2022 (Predecessor)
- 99.3 Estrella's Management's Discussion and Analysis of Financial Condition and Results of Operations
- Download Excel data file
- View Excel data file
ESLA similar filings
- 2 Feb 24 Changes in Registrant's Certifying Accountant
- 30 Jan 24 Estrella Immunopharma Announces $1 Million Share Repurchase Authorization
- 14 Nov 23 Amendments to Articles of Incorporation or Bylaws
- 5 Oct 23 Entry into a Material Definitive Agreement
- 20 Sep 23 Entry into a Material Definitive Agreement
- 18 Sep 23 TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination
- 18 Aug 23 TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination
Filing view
External links
Exhibit 21.1
List of Subsidiaries of Estrella Immunopharma, Inc.
Name of Subsidiary | Jurisdiction of Organization | |
Estrella Biopharma, Inc. | Delaware |